We have located links that may give you full text access.
Innovative chest physiotherapy techniques (the MetaNeb ® System) in the intubated child with extensive burns.
INTRODUCTION: The Metaneb® is a new generation Intrapulmonary Percussive Ventilation device utilised by the physiotherapist to assist airway clearance by providing calibrated oscillations during inspiration up to 3.8Hz. Predominantly used in the adult chronic respiratory patient, with anecdotal evidence in intubated patients, it was also proven to be safe in a paediatric lung model lab study. This case report outlines the first use of the Metaneb® with an intubated child in Australia. The 8 year old patient was retrieved to Lady Cilento Children's Hospital with 61% total body surface area flame burns. The child was difficult to ventilate, immobile, and had retained secretions. The chest x-ray (CXR) demonstrated multifocal regions of atelectasis.
STUDY OBJECTIVES: To report safe and effective use of the Metaneb® airway clearance in the paediatric intubated patient.
METHODS: The Metaneb® was applied using an open ended bagging circuit on Continuous High Frequency Oscillation mode for a period of 10 min per treatment. The circuit contained an inline nebuliser containing 5ml 0.9% normal saline. PEEP was maintained and variable volume breaths were delivered with suction performed as required. Outcome variables to be measured included sputum weight and quality, CXR, and Peak Inspiratory Pressure (PIP) values pre and post treatment. Vital signs were monitored throughout.
RESULTS: The patient's vital signs remained stable throughout intervention. After 4 days of treatment twice daily, there was resolution of focal changes on CXR, improvement in secretions, a reduction in PIP and the patient was extubated.
CONCLUSION: The Metaneb® was used safely and effectively in this patient to assist in resolution of respiratory pathology. Metaneb® provided a new option for physiotherapy treatment when positioning and handling restrictions limited usual care. This ultimately optimised PICU Length of stay and patient morbidity and mortality. Metaneb® provided by Hill-Rom Australia.
STUDY OBJECTIVES: To report safe and effective use of the Metaneb® airway clearance in the paediatric intubated patient.
METHODS: The Metaneb® was applied using an open ended bagging circuit on Continuous High Frequency Oscillation mode for a period of 10 min per treatment. The circuit contained an inline nebuliser containing 5ml 0.9% normal saline. PEEP was maintained and variable volume breaths were delivered with suction performed as required. Outcome variables to be measured included sputum weight and quality, CXR, and Peak Inspiratory Pressure (PIP) values pre and post treatment. Vital signs were monitored throughout.
RESULTS: The patient's vital signs remained stable throughout intervention. After 4 days of treatment twice daily, there was resolution of focal changes on CXR, improvement in secretions, a reduction in PIP and the patient was extubated.
CONCLUSION: The Metaneb® was used safely and effectively in this patient to assist in resolution of respiratory pathology. Metaneb® provided a new option for physiotherapy treatment when positioning and handling restrictions limited usual care. This ultimately optimised PICU Length of stay and patient morbidity and mortality. Metaneb® provided by Hill-Rom Australia.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app